Dr. Dmitry Shuster, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 486
Licensed in Illinois since 2017, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
IL license 036142458 (first issued 2017; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Medical Center Springfield, IL
- St Johns Hospital Springfield, IL
- Taylorville Memorial Hospital Taylorville, IL
- Abraham Lincoln Memorial Hospital Lincoln, IL
Medical groups
- Springfield Clinic, LLP (687 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 486
- Services billed
- 12,712
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 200 | 191 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 155 | 154 |
| Established patient office or other outpatient visit, 30-39 minutes | 109 | 94 |
| Biopsy of large bowel using a flexible endoscope | 90 | 90 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 70 | 51 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 53 | 52 |
| New patient office or other outpatient visit, 45-59 minutes | 50 | 50 |
| Measurement of liver stiffness | 47 | 46 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 35 | 24 |
| Established patient office or other outpatient visit, 40-54 minutes | 29 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Springfield, IL | 93 |
| Pantoprazole Sodium Other prescribers in Springfield, IL | 60 |
| Ursodiol Other prescribers in Springfield, IL | 54 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Springfield, IL | 47 |
| Peg 3350-Electrolyte (sodium chloride/nahco3/kcl/peg) | 42 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Springfield, IL | 42 |
| Sucralfate Other prescribers in Springfield, IL | 39 |
| Linzess (linaclotide) Other prescribers in Springfield, IL | 38 |
| Creon (lipase/protease/amylase) Other prescribers in Springfield, IL | 37 |
| Mesalamine Other prescribers in Springfield, IL | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 121 payments worth $116,899 in total to this clinician.
| AbbVie Inc. | $70,019 |
|---|---|
| Madrigal Pharmaceuticals | $40,190 |
| Perspectum Diagnostics LTD | $6,176 |
| Janssen Biotech, Inc. | $159 |
| Boston Scientific Corporation | $132 |
| Genzyme Corporation | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.56 |
| Aimmune Therapeutics, Inc. | $20.68 |
| Compensation for services other than consulting (speaking, faculty) | $97,165 |
|---|---|
| Travel and Lodging | $16,021 |
| Food and Beverage | $3,703 |
| Education | $10.48 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,900 |
| AbbVie Inc. Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,900 |
| AbbVie Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,900 |
| AbbVie Inc. Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,900 |
| Madrigal Pharmaceuticals Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
All 53 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Dec 22, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $1,400 |
| Madrigal Pharmaceuticals Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
| Madrigal Pharmaceuticals Dec 10, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to BLOOMINGTON, IL | $119 |
| AbbVie Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DECATUR, IL | $71.40 |
| Madrigal Pharmaceuticals Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
| Madrigal Pharmaceuticals Nov 17, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to BLOOMINGTON, IL | $113 |
| AbbVie Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Nov 12, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CHAMPAIGN, IL · in-kind | $931 |
| Madrigal Pharmaceuticals Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
| Madrigal Pharmaceuticals Nov 6, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to CHAMPAIGN, IL | $152 |
| Madrigal Pharmaceuticals Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| AbbVie Inc. Oct 22, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to QUINCY, IL · in-kind | $854 |
| AbbVie Inc. Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,900 |
| AbbVie Inc. Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,500 |
| Madrigal Pharmaceuticals Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| Madrigal Pharmaceuticals Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
| Madrigal Pharmaceuticals Oct 16, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to PEORIA, IL | $119 |
| AbbVie Inc. Oct 3, 2025 | Travel and Lodging travel to YPSILANTI, MI · in-kind | $1,835 |
| AbbVie Inc. Oct 3, 2025 | Travel and Lodging travel to YPSILANTI, MI · in-kind | $602 |
| Madrigal Pharmaceuticals Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| AbbVie Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,500 |
| Madrigal Pharmaceuticals Aug 27, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| Madrigal Pharmaceuticals Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
| Madrigal Pharmaceuticals Aug 20, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to CLAYTON, MO | $267 |
| Madrigal Pharmaceuticals Aug 20, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to CLAYTON, MO | $165 |
| Madrigal Pharmaceuticals Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,725 |
| AbbVie Inc. Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Jul 17, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $1,009 |
| AbbVie Inc. Jun 6, 2025 | Travel and Lodging travel to CINCINNATI, OH · in-kind | $130 |
| AbbVie Inc. Jun 6, 2025 | Travel and Lodging travel to CINCINNATI, OH · in-kind | $12.95 |
| Perspectum Diagnostics LTD May 30, 2025 | Travel and Lodging travel to Oxford, Great Britain (UK) · in-kind | $2,579 |
| AbbVie Inc. May 27, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $120 |
| AbbVie Inc. May 27, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $14.77 |
| AbbVie Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,900 |
| AbbVie Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| Perspectum Diagnostics LTD May 1, 2025 | Travel and Lodging travel to Amsterdam, Netherlands · in-kind | $197 |
| Janssen Pharmaceuticals, Inc Apr 7, 2025 | Education in-kind | $10.48 |
| AbbVie Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Apr 2, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $104 |
| AbbVie Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,400 |
| AbbVie Inc. Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,900 |
| Perspectum Diagnostics LTD Mar 14, 2025 | Travel and Lodging travel to Oxford, Great Britain (UK) · in-kind | $3,130 |
| AbbVie Inc. Feb 27, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $1,048 |
| AbbVie Inc. Feb 14, 2025 | Travel and Lodging travel to BLOOMFIELD HILLS, MI · in-kind | $75.00 |
| AbbVie Inc. Feb 14, 2025 | Travel and Lodging travel to BLOOMFIELD HILLS, MI · in-kind | $73.89 |
| AbbVie Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,900 |
| AbbVie Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,500 |
| AbbVie Inc. Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,100 |
| AbbVie Inc. Jan 13, 2025 | Travel and Lodging travel to CINCINNATI, OH · in-kind | $1,491 |
| AbbVie Inc. Jan 13, 2025 | Travel and Lodging travel to CINCINNATI, OH · in-kind | $422 |
| AbbVie Inc. Jan 13, 2025 | Travel and Lodging travel to CINCINNATI, OH · in-kind | $387 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $405,636 in research payments for these studies, mostly to the institutions running them.
- Multicenter, randomised, double-blind, placebo-controlled, 48 week, Phase III trial to evaluate the efficacy and safety of survodutide administered subcutaneously in participants with overweight or obesity and presume…
Boehringer Ingelheim International GmbH - A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
AbbVie Inc. · Active, not recruiting · NCT06880744 - Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie Inc. · Recruiting · NCT06548542
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.